title: [Myelodysplastic syndrome. What can be achieved with supportive therapy and new approaches].
authors: Martin
authors: M
authors: Bischoff
mesh_terms: D000074323:Alemtuzumab; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D000912:Antibodies, Neoplasm / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D017707:Erythrocyte Transfusion; D018380:Hematopoietic Stem Cell Transplantation; D006432:Hemochromatosis / Q000209:etiology / Q000628:therapy; D006801:Humans; D000077269:Lenalidomide; D009190:Myelodysplastic Syndromes / Q000175:diagnosis / Q000628:therapy*; D017713:Platelet Transfusion; D013792:Thalidomide / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm; D000970:Antineoplastic Agents; D000074323:Alemtuzumab; D013792:Thalidomide; D000077269:Lenalidomide